Both the Cdk5 and GSK-3β phosphorylation of CRMP-2 have been shown to be increased in the cortex and hippocampus of the triple transgenic mouse (PS1/APP/Tau mutant), along with the double transgenic mouse (PS1/APP mutant), that develop AD-like plaques along with NFTs. Here, CDK5 is linked to Alzheimer disease.